Sarepta Therapeutics (SRPT) Gross Profit (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 559.16% |
| Dec 31, 2025 | -82.21% |
| Sep 30, 2025 | -45.79% |
| Jun 30, 2025 | 10,937.46% |
| Mar 31, 2025 | -100.80% |
| Dec 31, 2024 | 40.12% |
| Sep 30, 2024 | 17.93% |
| Jun 30, 2024 | -12.27% |
| Mar 31, 2024 | -13.46% |
| Dec 31, 2023 | 42.26% |
| Sep 30, 2023 | 2,582.66% |
| Jun 30, 2023 | -105.43% |
| Mar 31, 2023 | 57.88% |
| Dec 31, 2022 | -17.54% |
| Sep 30, 2022 | -3.22% |
| Jun 30, 2022 | 1,937.31% |
| Mar 31, 2022 | -111.76% |
| Dec 31, 2021 | -51.66% |
| Sep 30, 2021 | 35.67% |
| Jun 30, 2021 | -1.81% |
| Mar 31, 2021 | 138,327.78% |
| Dec 31, 2020 | -98.80% |
| Sep 30, 2020 | -41.00% |
| Jun 30, 2020 | 1,999.01% |
| Mar 31, 2020 | -99.29% |
| Dec 31, 2019 | -1.70% |
| Sep 30, 2019 | 9.21% |
| Jun 30, 2019 | 5.07% |
| Mar 31, 2019 | 5.15% |
| Dec 31, 2018 | 2.20% |
| Sep 30, 2018 | 4.42% |
| Jun 30, 2018 | 13.17% |
| Mar 31, 2018 | 9.85% |
| Dec 31, 2017 | 25.32% |
| Sep 30, 2017 | 24.26% |
| Jun 30, 2017 | 114.08% |